masoprocol and Leukemia, Myeloid, Acute

masoprocol has been researched along with Leukemia, Myeloid, Acute in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seaman, WE; Woodcock, J1
Bloch, A; Gessner, T; Wikiel, H; Zhao, L1
Hoffbrand, AV; Khan, MA; Mehta, A; Tahami, F; Wickremasinghe, RG; Wright, F1

Other Studies

3 other study(ies) available for masoprocol and Leukemia, Myeloid, Acute

ArticleYear
Human and murine natural killer cell activity may require lipoxygenation of arachidonic acid.
    The Journal of allergy and clinical immunology, 1984, Volume: 74, Issue:3 Pt 2

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Anti-Inflammatory Agents; Antibody-Dependent Cell Cytotoxicity; Antioxidants; Arachidonic Acid; Arachidonic Acids; Catechols; Cell Line; Humans; Indomethacin; Killer Cells, Natural; Leukemia, Myeloid, Acute; Masoprocol; Pyrazoles

1984
Differential effect of growth- and differentiation-inducing factors on the release of eicosanoids and phospholipids from ML-1 human myeloblastic leukemia cells.
    Biochimica et biophysica acta, 1994, Mar-03, Volume: 1211, Issue:2

    Topics: Arachidonic Acid; Caffeic Acids; Cell Differentiation; Cell Division; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; Insulin-Like Growth Factor I; Leukemia, Myeloid, Acute; Lipoxygenase Inhibitors; Masoprocol; Phospholipids; Transferrin; Transforming Growth Factor beta; Tritium; Tumor Cells, Cultured

1994
MK 886, an antagonist of leukotriene generation, inhibits DNA synthesis in a subset of acute myeloid leukaemia cells.
    Leukemia research, 1993, Volume: 17, Issue:9

    Topics: Adult; Aged; Child; DNA, Neoplasm; Female; Humans; Indoles; Leukemia, Myeloid, Acute; Leukotriene Antagonists; Male; Masoprocol; Middle Aged

1993